Company: Allscripts Healthcare Solutions, Inc.
Kaskela Law LLC is investigating Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (“Allscripts” or the “Company”) on behalf of the Company’s stockholders.
On May 3, 2019, the Company disclosed that “Practice Fusion, acquired by Allscripts on February 13, 2018, received in March 2017 a request for documents and information from the U.S. Attorney’s Office for the District of Vermont” pursuant to a civil investigative demand, and that “[i]n March 2019, Practice Fusion received a grand jury subpoena in connection with a related criminal investigation.” Allscripts further detailed how “[t]he document and information requests received by Practice Fusion relate to both the certification Practice Fusion obtained in connection with the U.S. Department of Health and Human Services’ Electronic Health Record Incentive Program and Practice Fusion’s compliance with the Anti-Kickback Statute and HIPAA as it relates to certain business practices engaged in by Practice Fusion.” Finally, the Company reported that “[t]he outcome of the government investigation of Practice Fusion or any future government investigations of our other businesses could have a material adverse effect on our business, financial condition and operating results.”
The investigation seeks to determine whether Allscripts’ officers and directors violated the securities laws and/or failed to properly fulfill their fiduciary duties to the Company and its stockholders in connection with the above.
Allscripts stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258–1585 or (888) 715–1740, or by completing the information form on this page, to discuss this investigation and their legal rights and options.